From Volumetry to Intelligent Biostimulation: Controlled Regeneration as the Future of Aesthetic Medicine
Autologous exosomes in skin regeneration
On 10 December 2025, Beautyeurope.eu hosted a Christmas gathering in Warsaw, combined with an exclusive preview of a new biostimulator set to launch on the global market in the first quarter of 2026.
MEC Regenerate® is an innovative, multi-stage biostimulation system designed to support the regeneration of the extracellular matrix. It promotes gradual, biologically synchronised tissue renewal while respecting the body’s natural regenerative processes.
The MEC Regenerate® formula is based on ingredients well known in aesthetic medicine. However, their unique combination means that they do not act as individual substances, but rather as a coherent, synergistic system. Its cascading and mutually supportive mechanisms of action enable both an immediate effect and long-term remodelling and regeneration of the skin’s structure.
The product is characterised by 100% biological compatibility, no allergic reactions, visible yet natural-looking results, safety and a high degree of predictability — all reflecting a trend that is gaining increasing importance in aesthetic medicine.
This innovative approach can be described as intelligent skin bioregeneration, while the unique formula has been submitted for patent protection, highlighting its innovative nature. The product is currently at the final stage of MDR certification.
The event was attended by representatives of 303 Pharma srl, the Italian manufacturer of MEC Regenerate®: Marco Benedetti, CEO and Co-Founder of the company, and Mauro Forti, Commercial Director. Beautyeurope.eu trainers Dr Barbara Parda, Dr Magdalena Kędzia, Dr Agnieszka Górna and Dr Krzysztof Cudzik, as well as our teams from Poland and the UK, were also present.
The gathering was not only an opportunity to exchange knowledge and experience, but also a preview of a new direction in the development of modern aesthetic medicine in the years ahead.
